These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37318773)

  • 1. Efficacy of Dupilumab for Severe Atopic Dermatitis Co-occurring With Asthma in a Real-World Setting.
    Pose K; Laorden D; Hernández N; Villamañán E; Quirce S; Domínguez-Ortega J
    J Investig Allergol Clin Immunol; 2023 Jun; 33(3):217-219. PubMed ID: 37318773
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab use in atopic dermatitis and beyond in skin diseases.
    Fourzali K; Golpanian RS; Yosipovitch G
    Immunotherapy; 2020 Dec; 12(17):1221-1235. PubMed ID: 32892674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients.
    Guex-Crosier Y; Di-Lucca J; Häusermann P; Laffitte E; Saulite I; Schmid-Grendelmeier P; Schürch K; Thormann K; Simon D
    Swiss Med Wkly; 2021 Aug; 151():w30020. PubMed ID: 34495603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study.
    Guédon C; Tauber M; Linder C; Paul C; Shourick J
    Ann Dermatol Venereol; 2023 Sep; 150(3):215-216. PubMed ID: 37598014
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.
    Benzecry V; Pravettoni V; Segatto G; Marzano AV; Ferrucci S
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):261-263. PubMed ID: 32732182
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice.
    Tauber M; Apoil PA; Richet C; Laurent J; De Bonnecaze G; Mouchon E; Cassagne M; Marguery MC; Hegazy S; Konstantinou MP; Severino M; Uthurriague C; Giordano-Labadie F; Didier A; Paul C
    Br J Dermatol; 2019 Jun; 180(6):1551-1552. PubMed ID: 30633329
    [No Abstract]   [Full Text] [Related]  

  • 9. Dupilumab in the treatment of asthma.
    Grey A; Katelaris CH
    Immunotherapy; 2019 Jul; 11(10):859-872. PubMed ID: 31218914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab in a child with severe atopic dermatitis and severe asthma-a rare case with severe limbitis and exercise-induced anaphylaxis.
    Poelhekken M; Rosenberg FM; Oldhoff JM; Romeijn GLE; Wijdh RHJ; Bocca-Tjeertes IFA; Schuttelaar MLA
    Int J Dermatol; 2022 Oct; 61(10):e400-e401. PubMed ID: 35567488
    [No Abstract]   [Full Text] [Related]  

  • 11. Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis.
    Tolino E; Proietti I; Sarni A; Bernardini N; Mambrin A; Balduzzi V; Maddalena P; Marchesiello A; Michelini S; Volpe S; Skroza N; Potenza C
    Dermatol Ther; 2021 Jan; 34(1):e14596. PubMed ID: 33244860
    [No Abstract]   [Full Text] [Related]  

  • 12. [Principles of modern diagnosis and treatment of atopic dermatitis and bronchial asthma: Clinical case].
    Shogenova MS; Hutueva SH; Shogenova LS
    Ter Arkh; 2022 Mar; 94(3):427-433. PubMed ID: 36286909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of dupilumab in patients with atopic dermatitis: expert opinion.
    Francuzik W; Alexiou A; Worm M
    Expert Opin Drug Saf; 2021 Sep; 20(9):997-1004. PubMed ID: 34114910
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunobiologic treatments for severe asthma, atopic dermatitis, and chronic urticaria.
    Chiarella SE
    Allergy Asthma Proc; 2019 Nov; 40(6):485-489. PubMed ID: 31690400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.
    Halling AS; Loft N; Silverberg JI; Guttman-Yassky E; Thyssen JP
    J Am Acad Dermatol; 2021 Jan; 84(1):139-147. PubMed ID: 32822798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis.
    Boguniewicz M; Beck LA; Sher L; Guttman-Yassky E; Thaçi D; Blauvelt A; Worm M; Corren J; Soong W; Lio P; Rossi AB; Lu Y; Chao J; Eckert L; Gadkari A; Hultsch T; Ruddy M; Mannent LP; Graham NMH; Pirozzi G; Chen Z; Ardeleanu M
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1212-1223.e6. PubMed ID: 33453450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.
    Brodska P; Panzner P; Sedlacek D; Terl M; Cetkovska P
    Dermatol Ther; 2020 Nov; 33(6):e14159. PubMed ID: 32776586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study.
    Pezzolo E; Rossi M; Caroppo F; Bianchelli T; Belloni Fortina A; Giacchetti A; Calzavara Pinton P; Naldi L
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e757-e759. PubMed ID: 36662631
    [No Abstract]   [Full Text] [Related]  

  • 19. Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States.
    Emmerich VK; Williams JA; Hrin ML; Feldman SR; Strowd LC
    Int J Dermatol; 2024 Apr; 63(4):524-525. PubMed ID: 38093434
    [No Abstract]   [Full Text] [Related]  

  • 20. A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
    Stingeni L; Bianchi L; Antonelli E; Caroppo ES; Ferrucci SM; Gurioli C; Ortoncelli M; Fabbrocini G; Nettis E; Schena D; Napolitano M; Gola M; Bonzano L; Rossi M; Belloni Fortina A; Balato A; Peris K; Foti C; Guarneri F; Romanelli M; Patruno C; Savoia P; Esposito M; Russo F; Errichetti E; Bianchelli T; Bianchi L; Pellacani G; Feliciani C; Offidani A; Corazza M; Micali G; Milanesi N; Malara G; Chiricozzi A; Tramontana M; Hansel K;
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e384-e388. PubMed ID: 36225088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.